Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm.

MLA

Checa, Rocío, et al. “Efficacy, Safety and Tolerance of Imidocarb Dipropionate versus Atovaquone or Buparvaquone plus Azithromycin Used to Treat Sick Dogs Naturally Infected with the Babesia Microti-like Piroplasm.” Parasites & Vectors, vol. 10, no. 1, Mar. 2017, p. 145. EBSCOhost, https://doi.org/10.1186/s13071-017-2049-0.

APA

Checa, R., Montoya, A., Ortega, N., González-Fraga, J. L., Bartolomé, A., Gálvez, R., Marino, V., & Miró, G. (2017). Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm. Parasites & Vectors, 10(1), 145. https://doi.org/10.1186/s13071-017-2049-0

Chicago

Checa, Rocío, Ana Montoya, Nieves Ortega, José Luis González-Fraga, Adrián Bartolomé, Rosa Gálvez, Valentina Marino, and Guadalupe Miró. 2017. “Efficacy, Safety and Tolerance of Imidocarb Dipropionate versus Atovaquone or Buparvaquone plus Azithromycin Used to Treat Sick Dogs Naturally Infected with the Babesia Microti-like Piroplasm.” Parasites & Vectors 10 (1): 145. doi:10.1186/s13071-017-2049-0.